Feb 18, 2019
Two Penn State College of Medicine professors, Drs. Paul Haidet and Xuemei Huang, have been named university distinguished professors by Penn State in recognition of their academic and research achievements.
Researchers from Penn State College of Medicine were awarded 38 grants in January to engage in research that will increase medical and scientific knowledge.
Feb 15, 2019
Charleen Hsuan, JD, PhD, recently joined Penn State Clinical and Translational Science Institute as regulatory impact lead, Research Methods Core.
Nilam Ram, PhD, professor of human development and family studies, will present “Analysis of Experience Sampling and Ecological Momentary Assessment Data, Part 2: Using Multilevel Models of Intraindividual Covariation” at the next Biostatistics, Epidemiology and Research Design (BERD) Recent Topics in Research Methods Seminar Series.
Feb 14, 2019
The PA Breast Cancer Coalition awarded Dr. David Waning of Penn State Cancer Institute $50,000 to advance his studies of metastatic breast cancer treatment.
Feb 13, 2019
For the research investigators and physicians who make up the Four Diamonds Pediatric Cancer Research Center at Penn State Health Children's Hospital, the impact of THON is felt long after the 46-hour dance marathon is over.
Feb 6, 2019
“Laws and Regulations in Translational Research: The Role of Law in Health Policy” will be presented at the next Penn State Clinical and Translational Science Institute Bench to Bedside and Beyond Seminar […]
A Bridges to Translation grant from Penn State Clinical and Translational Science Institute helped to fund a project on how immune cells react and adapt to stress.
Penn State College of Medicine researchers say some cannabinoid compounds may inhibit the growth of colon cancer cells in the lab.
Feb 5, 2019
The American Cancer Society has awarded $728,000 in funding to Penn State College of Medicine researcher Shirley Bluethmann to study whether exercise reduces joint pain and increases adherence to a type of lifesaving medication called aromatase inhibitors in women who have survived breast cancer.
